Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Christopher Su"'
Autor:
Feng Wang, Ayse Ece Cali Daylan, Lei Deng, Jihua Yang, Janaki Sharma, Christopher Su, Shenduo Li, Xingxing Zang, Balazs Halmos, Alain Borczuk, Haiying Cheng
Publikováno v:
Cancers, Vol 15, Iss 13, p 3372 (2023)
Immunotherapy has transformed lung cancer management, but PSC remains an aggressive subtype with a poor prognosis. This study investigates the differential expression of PD-L1 and alternative immune checkpoints (ICs; B7x, B7-H3, and HHLA2), and genet
Externí odkaz:
https://doaj.org/article/aca5c64cc23c416ab8f7a20ed50fd47b
Autor:
Cheng, Feng Wang, Ayse Ece Cali Daylan, Lei Deng, Jihua Yang, Janaki Sharma, Christopher Su, Shenduo Li, Xingxing Zang, Balazs Halmos, Alain Borczuk, Haiying
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3372
Immunotherapy has transformed lung cancer management, but PSC remains an aggressive subtype with a poor prognosis. This study investigates the differential expression of PD-L1 and alternative immune checkpoints (ICs; B7x, B7-H3, and HHLA2), and genet
Autor:
Michael A. Thompson, Jeremy L. Warner, Leyre Zubiri, Trisha M. Wise-Draper, Pallawi Torka, Christopher Su, Aditi Shastri, Sumit A. Shah, Andrew Schmidt, Rachel Rosovski, Pedram Razavi, Matthew M. Puc, Andrew J. Portuguese, Hyma V. Polimera, Adam J. Olszewski, Taylor K. Nonato, Amanda Nizam, Gayathri Nagaraj, Rana R. McKay, Gary H. Lyman, Xuanyi Li, Eric Lau, Tahir Latif, Chris Labaki, Daniel H. Kwon, Nicole M. Kuderer, Vadim S. Koshkin, Elizabeth J. Klein, Anup Kasi, Monika Joshi, Nathalie A. Johnson, Clara Hwang, Daniel Hausrath, Shilpa Gupta, Christopher R. Friese, Devendra KC, Jacob C. Cogan, Cecilia A. Castellano, Mehmet Asim Bilen, Stephanie Berg, Babar Bashir, Ziad Bakouny, Joy Awosika, Sarit E. Assouline, Melissa Accordino, Alicia Beeghly-Fadiel, Matthias Weiss, Catherine Stratton, Keith E. Stockerl-Goldstein, R. Alejandro Sica, Dimpy P. Shah, Daniel P. Mundt, Sanjay Mishra, Ruben A. Mesa, Shailesh Advani, Yu Shyr, Chih-Yuan Hsu, Ryan C. Lynch, Divaya Bhutani, Samuel M. Rubinstein
Patients with B-lymphoid malignancies have been consistently identified as a population at high risk of severe COVID-19. Whether this is exclusively due to cancer-related deficits in humoral and cellular immunity, or whether risk of severe COVID-19 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a8d5a0ca3f513af54198bd82bbe3af3
https://doi.org/10.1158/2643-3230.c.6550638
https://doi.org/10.1158/2643-3230.c.6550638
Autor:
Michael A. Thompson, Jeremy L. Warner, Leyre Zubiri, Trisha M. Wise-Draper, Pallawi Torka, Christopher Su, Aditi Shastri, Sumit A. Shah, Andrew Schmidt, Rachel Rosovski, Pedram Razavi, Matthew M. Puc, Andrew J. Portuguese, Hyma V. Polimera, Adam J. Olszewski, Taylor K. Nonato, Amanda Nizam, Gayathri Nagaraj, Rana R. McKay, Gary H. Lyman, Xuanyi Li, Eric Lau, Tahir Latif, Chris Labaki, Daniel H. Kwon, Nicole M. Kuderer, Vadim S. Koshkin, Elizabeth J. Klein, Anup Kasi, Monika Joshi, Nathalie A. Johnson, Clara Hwang, Daniel Hausrath, Shilpa Gupta, Christopher R. Friese, Devendra KC, Jacob C. Cogan, Cecilia A. Castellano, Mehmet Asim Bilen, Stephanie Berg, Babar Bashir, Ziad Bakouny, Joy Awosika, Sarit E. Assouline, Melissa Accordino, Alicia Beeghly-Fadiel, Matthias Weiss, Catherine Stratton, Keith E. Stockerl-Goldstein, R. Alejandro Sica, Dimpy P. Shah, Daniel P. Mundt, Sanjay Mishra, Ruben A. Mesa, Shailesh Advani, Yu Shyr, Chih-Yuan Hsu, Ryan C. Lynch, Divaya Bhutani, Samuel M. Rubinstein
Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44698d30596b4e81fbac34bfa3f7919a
https://doi.org/10.1158/2643-3230.22544427.v1
https://doi.org/10.1158/2643-3230.22544427.v1
Autor:
Christopher Su
Publikováno v:
JCO Oncology Practice. 18:607-609
Autor:
Jacob E. Berchuck, Catherine Handy Marshall, Nabil Adra, Fadi Taza, Emmanuel S. Antonarakis, Hao Wang, Oren Smaletz, Wei Fu, Rahul Aggarwal, Albert E Holler, Neeraj Agarwal, Pedro C. Barata, Nellie Nafissi, Alexandra O. Sokolova, Adam Kessel, Panagiotis J. Vlachostergios, Christopher Su, Cora N. Sternberg, Ajjai Alva, Heather H. Cheng, Ryan Ashkar, Alan H. Bryce, Costantine Albany, Mary-Ellen Taplin, A. Oliver Sartor, Diogo Assed Bastos
Publikováno v:
JCO Precision Oncology. :1200-1220
PURPOSE Two poly (ADP-ribose) polymerase (PARP) inhibitors (olaparib and rucaparib) are US Food and Drug Administration–approved for patients with metastatic castration-resistant prostate cancer (mCRPC) harboring BRCA1/ 2 mutations, but the relativ
Autor:
Christopher Su, J Christine Ye
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-18 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
The pace of innovation of multiple myeloma therapy in recent years is remarkable with the advent of monoclonal antibodies and the approval of novel agents with new mechanisms of action. Emerging therapies are on the horizon for clinical approval with
Autor:
Zhuoer Xie, Vadim S. Koshkin, Elizabeth Marie Wulff-Burchfield, Jeffrey P. Henderson, Christopher Su, Peter Paul Yu, Sanjay Mishra, Jonathon W. Senefeld, Daniel Blake Flora, Pankil Shah, Dimpy P. Shah, Clara Hwang, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri, Jeremy L. Warner, Anthony P. Gulati, Elizabeth Robilotti, Michael A. Thompson, Esperanza B. Papadopoulos, Elizabeth A. Griffiths
Publikováno v:
JAMA Oncology
Key Points Question Is convalescent plasma therapy associated with improved outcomes of hospitalized patients with COVID-19 and hematologic cancer? Findings In this cohort study of 966 patients with hematologic cancer and COVID-19, after adjustment f
Autor:
Minal R. Patel, Christopher Su
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:HSR21-071
Autor:
Devi Das, Madhurima Khasnobis, Susmita Dutta, Suchismita Hoda, Arkaprovo Pal, Christopher Sundström, Martin Kraepelien, Arun Kandasamy, Swati Mehta, Neha Dahiya, Indranil Saha, Asim Saha, Amit Chakrabarti
Publikováno v:
International Journal of Noncommunicable Diseases, Vol 9, Iss 2, Pp 91-98 (2024)
Background: Older adults of low- and middle-income countries (LMICs) have a higher prevalence of mental health disorders compared to high-income countries, which can be attributed to a combination of social factors (such as isolation and loss of spou
Externí odkaz:
https://doaj.org/article/5e4951a053c34a9d9cb268ab2206361b